Comparison Between Beta-Blockers with Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers with Angiotensin II Type I Receptor Blockers in ST-Segment Elevation Myocardial Infarction After Successful Percutaneous Coronary Intervention with Drug-Eluting Stents.
Yong Hoon KimAe-Young HerMyung Ho JeongByeong-Keuk KimSeung-Yul LeeSung-Jin HongDong-Ho ShinJung-Sun KimYoung-Guk KoDonghoon ChoiMyeong-Ki HongYangsoo JangPublished in: Cardiovascular drugs and therapy (2019)
The combination BB with ACEI may be beneficial for reducing MACE in STEMI patients after successful PCI with DES than the BB with ARB.
Keyphrases
- angiotensin converting enzyme
- st segment elevation myocardial infarction
- percutaneous coronary intervention
- angiotensin ii
- st elevation myocardial infarction
- acute myocardial infarction
- acute coronary syndrome
- antiplatelet therapy
- coronary artery disease
- vascular smooth muscle cells
- coronary artery bypass grafting
- end stage renal disease
- growth factor
- newly diagnosed
- chronic kidney disease
- coronary artery bypass
- ejection fraction
- prognostic factors
- peritoneal dialysis
- recombinant human
- electronic health record
- drug induced
- patient reported
- heart failure